A Newsletter from Becton Dickinson Va C U Tainer Systems
نویسنده
چکیده
Also in this issue Editorial Commentary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2 IN CONTRO L : Postexposure Prophylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . .3 Medical Lore: Hemophilia — A Look Back............................5 F e a t u r e : An Overview of the Infectious Substance Transport Requirements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6 Te chnical Exch a n ge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7 B DVS New Product New s : Reducing Exposure to Latex. . . . . . . . . . . . . . . . . . . . . . . . . . . .B a ck Cov e r Upcoming Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B a ck Cov e r Route to: Continued on page 2 F a l l / Winter 1998 VOLUME 8 Number 3
منابع مشابه
Observations on the use of the Becton Dickinson Fibrometer
SYNOPSIS An electro-mechanical instrument for use in both Thrombotest and Quick one-stage systems of anticoagulant control is described and the results obtained using it are compared with those obtained in the standard manual method. These figures show a very satisfactory degree of correlation, and it is concluded that the instrument would be of value in laboratories, particularly those control...
متن کاملSyringe plunger contamination by hazardous drugs: a comparative study.
AIM The purpose of this study was to perform a comparative cyclophosphamide contamination level test with Becton Dickinson® syringe plungers with Phaseal® Closed System Transfer Devices and Equashield® syringe plungers under routine oncological compounding conditions. METHOD The ChemoGlo™ sampling kit and analysis services were used to test for cyclophosphamide contamination levels on the syr...
متن کاملHOME CME/CE INFORMATION PROGRAM DIRECTORS NEWSLETTER ARCHIVE EDIT PROFILE RECOMMEND TO A COLLEAGUE eDiabetes Review VOLUME 2, ISSUE 10 RISKS AND BENEFITS OF SGLT-2 INHIBITOR AGENTS
Anne Peters, MD has indicated that she has been on the advisory board or consulted for Abbott Diabetes Care, Becton Dickinson, Bigfoot Biomedical, Biodel, Boehringer Ingelheim, CVS/Caremark, Eli Lilly and Company, Bristol-Myers Squibb/AstraZeneca, Intarcia, Merck, Janssen, Lexicon, Novo Nordisk, OptumRx, and Thermalin. She has received research grant funding from Janssen and Medtronic Foundatio...
متن کاملSafe injection practice (Safe-1 program).
WHO defines Safe Injection, as an injection that does no harm to recipients; does not expose the health care worker to any risk; and does not result in waste that is dangerous for the community. In India, 300 crore injections are given in an year out of which 180 crore are unsafe; diseases transmitted through unsafe injection practices include hepatitis B: 21million, hepatitis C: 2 million, and...
متن کاملTen years transmission of the new variant of Chlamydia trachomatis in Sweden: prevalence of infections and associated complications
OBJECTIVES In 2006, a new variant of Chlamydia trachomatis (nvCT) was discovered in Sweden. It has a deletion in the plasmid resulting in failed detection by the single target systems from Abbott and Roche used at that time, whereas the third system used, from Becton Dickinson (BD), detects nvCT. The proportion of nvCT was initially up to 65% in counties using Abbott/Roche systems. This study a...
متن کامل